Results 21 to 30 of about 2,744,410 (300)

Variability in intrinsic drug tolerance in <i>Mycobacterium tuberculosis</i> corresponds with phylogenetic lineage. [PDF]

open access: yesAntimicrob Agents Chemother
Drug tolerance allows bacteria to survive extended exposure to bactericidal drugs and is thought to play a role in drug resistance evolution. In Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), multidrug-resistant TB outbreaks ...
March VFA   +10 more
europepmc   +2 more sources

Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to antifungal compounds

open access: yeseLife, 2023
Candida albicans, an opportunistic human pathogen, poses a significant threat to human health and is associated with significant socio-economic burden. Current antifungal treatments fail, at least in part, because C.
Vanessa Dumeaux   +12 more
doaj   +1 more source

VapC21 Toxin Contributes to Drug-Tolerance and Interacts With Non-cognate VapB32 Antitoxin in Mycobacterium tuberculosis

open access: yesFrontiers in Microbiology, 2020
The prokaryotic ubiquitous Toxin-antitoxin (TA) modules encodes for a stable toxin and an unstable antitoxin. VapBC subfamily is the most abundant Type II TA system in M. tuberculosis genome.
Arun Sharma   +10 more
doaj   +1 more source

Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years

open access: yesFrontiers in Pediatrics, 2021
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce.
Justyna Sieber   +4 more
doaj   +1 more source

Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis. [PDF]

open access: yesFront Cell Infect Microbiol, 2022
Suboptimal efficacy of the current antibiotic regimens and frequent emergence of antibiotic-resistant Mycobacterium tuberculosis (Mtb), an etiological agent of tuberculosis (TB), render TB the world’s deadliest infectious disease before the COVID-19 ...
Eoh H, Liu R, Lim J, Lee JJ, Sell P.
europepmc   +2 more sources

Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
IntroductionResistance against anti-Leishmania drugs (DR) has been studied for years, giving important insights into long-term adaptations of these parasites to drugs, through genetic modifications.
Marlene Jara   +6 more
doaj   +1 more source

Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans

open access: yesFrontiers in Microbiology, 2020
Candida albicans is an important human pathogen and a major concern in intensive care units around the world. C. albicans infections are associated with a high mortality despite the use of antifungal treatments.
Eric Delarze   +13 more
doaj   +1 more source

The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer

open access: yesFrontiers in Genetics, 2023
Ovarian cancer affects the female reproductive system and is the primary cause of cancer related mortality globally. The imprecise and non-specific nature of ovarian cancer symptoms often results in patients being diagnosed at an advanced stage, with ...
Biqing Chen   +3 more
doaj   +1 more source

Activity Based Tolerance Allocation (ABTA) – Driving tolerance synthesis by evaluating its global cost [PDF]

open access: yes, 2009
This paper deals with tolerance allocation driven by an activity based approach. Its main objective is to rationally give a good indicator of the relevance of tolerances values fixed by designers.
MARTIN, Patrick   +3 more
core   +1 more source

Distinct Effects of Moxifloxacin and Bedaquiline on Growing and ‘Non-Culturable’ Mycobacterium abscessus

open access: yesMicroorganisms, 2023
Mycobacterium abscessus has recently emerged as the cause of an increasing number of human infections worldwide. Unfortunately, it is highly resistant to existing drugs, and new specific agents to combat M. abscessus have not yet been found.
Andrey L. Mulyukin   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy